메뉴 건너뛰기




Volumn 60, Issue 5, 2012, Pages 473-482

Ultrasensitive assessment of residual low-level HIV Viremia in HAART-treated patients and risk of virological failure

Author keywords

HAART; HIV RNA; low level viremia; residual viremia; ultrasensitive assay; virologic failure

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; VIRUS RNA;

EID: 84864283538     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182567a57     Document Type: Article
Times cited : (80)

References (39)
  • 1
    • 33748068118 scopus 로고    scopus 로고
    • Rates of diseases progression according to initial highly active antiretroviral therapy regimen: A collaborative analysis of 12 prospective cohort studies
    • The Antiretroviral Therapy Cohort Collaboration
    • The Antiretroviral Therapy Cohort Collaboration. Rates of diseases progression according to initial highly active antiretroviral therapy regimen: a collaborative analysis of 12 prospective cohort studies. J Infect Dis. 2006;194:612-622.
    • (2006) J Infect Dis , vol.194 , pp. 612-622
  • 3
    • 0036972260 scopus 로고    scopus 로고
    • Analysis of virological efficacy in trials of antiretroviral regimens: Drawbacks of not including viral load measurements after premature discontinuation of therapy
    • Kirk O, Pedersen C, Law M, et al. Analysis of virological efficacy in trials of antiretroviral regimens: drawbacks of not including viral load measurements after premature discontinuation of therapy. Antivir Ther. 2002;7:271-281. (Pubitemid 36427132)
    • (2002) Antiviral Therapy , vol.7 , Issue.4 , pp. 271-281
    • Kirk, O.1    Pedersen, C.2    Law, M.3    Gulick, R.M.4    Moyle, G.5    Montaner, J.6    Eron Jr., J.J.7    Phillips, A.N.8    Lundgren, J.D.9
  • 4
    • 52749083531 scopus 로고    scopus 로고
    • British HIV Association guidelines for the treatment of hIV-1-infected adults with antiretroviral therapy
    • on behalf of the BHIVA Treatment Guidelines Writing Group
    • Gazzard BG, on behalf of the BHIVA Treatment Guidelines Writing Group. British HIV Association guidelines for the treatment of hIV-1-infected adults with antiretroviral therapy. HIV Med. 2008;9:563-608.
    • (2008) HIV Med , vol.9 , pp. 563-608
    • Gazzard, B.G.1
  • 5
    • 84855616052 scopus 로고    scopus 로고
    • Panel On Antiretroviral Guidelines For Adult And Adolescents Department of Health and Human Services Accessed May 2011
    • Panel on antiretroviral guidelines for adult and adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Department of Health and Human Services; 2011:1-166. Available at: http//www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed May 2011.
    • (2011) Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents , pp. 1-166
  • 6
    • 77954692660 scopus 로고    scopus 로고
    • Antiretroviral treatment of adult HIV infection-2010. Recommendations of the IAS-USA panel
    • Thompson MA, Aberg JA, Cahn P, et al. Antiretroviral treatment of adult HIV infection-2010. Recommendations of the IAS-USA Panel. JAMA. 2010;304:321-333.
    • (2010) JAMA , vol.304 , pp. 321-333
    • Thompson, M.A.1    Aberg, J.A.2    Cahn, P.3
  • 8
    • 60049097896 scopus 로고    scopus 로고
    • Ultrasensitive assessment of residual HIV viremia in haart-treated patients with persistently undetectable plasma HIV-RNA: A cross-sectional study
    • Bonora S, Nicastri E, Calcagno A, et al. Ultrasensitive assessment of residual HIV viremia in HAART-treated patients with persistently undetectable plasma HIV-RNA: a cross-sectional study. J Med Virol. 2009;81:400-405.
    • (2009) J Med Virol , vol.81 , pp. 400-405
    • Bonora, S.1    Nicastri, E.2    Calcagno, A.3
  • 9
    • 79957608413 scopus 로고    scopus 로고
    • Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of hiv-1 infected persons
    • Antinori A, Marcotullio S, Ammassari A, et al. Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. New Microbiol. 2011;34:109-146.
    • (2011) New Microbiol , vol.34 , pp. 109-146
    • Antinori, A.1    Marcotullio, S.2    Ammassari, A.3
  • 10
    • 62749199717 scopus 로고    scopus 로고
    • Comparative evaluation of the VERSANT hiv-1 RNA 1.0 kinetic PCR molecular system (kPCR) for the quantification of hiv-1 plasma viral load
    • Ruelle J, Jnaoui K, Lefevre I, et al. Comparative evaluation of the VERSANT HIV-1 RNA 1.0 kinetic PCR molecular system (kPCR) for the quantification of HIV-1 plasma viral load. J Clin Virol. 2009; 44:297-301.
    • (2009) J Clin Virol , vol.44 , pp. 297-301
    • Ruelle, J.1    Jnaoui, K.2    Lefevre, I.3
  • 11
    • 67949107943 scopus 로고    scopus 로고
    • Evaluation of the new VERSANT hiv-1 RNA 1.0 assay (kPCR) for quantitative detection of human immunodeficiency virus type 1 RNA
    • Troppan KT, Steltzl E, Violan D, et al. Evaluation of the new VERSANT HIV-1 RNA 1.0 assay (kPCR) for quantitative detection of human immunodeficiency virus type 1 RNA. J Clin Virol. 2009;46:69-74.
    • (2009) J Clin Virol , vol.46 , pp. 69-74
    • Troppan, K.T.1    Steltzl, E.2    Violan, D.3
  • 12
    • 2442670063 scopus 로고    scopus 로고
    • Detection of HIV-1 antiretroviral resistance from patients with persistently low but detectable viraemia
    • DOI 10.1016/j.jviromet.2004.02.015, PII S0166093404000655
    • Mackie N, Dustan S, McClure MO, et al. Detection of HIV-1 antiretroviral resistance from patients with persistently low but detectable viremia. J Virol Methods. 2004;119:73-78. (Pubitemid 38670397)
    • (2004) Journal of Virological Methods , vol.119 , Issue.2 , pp. 73-78
    • Mackie, N.1    Dustan, S.2    McClure, M.O.3    Weber, J.N.4    Clarke, J.R.5
  • 13
    • 84864287720 scopus 로고    scopus 로고
    • Rapid, robust and sustained antiviral response with once-daily dolutegravir, a next generation integrase inhibitor in combination therapy in antiretroviral-naïve adults: 48 week results from SPRING-1
    • July 17-20 Rome, Italy. Abstract TUAB01
    • Van Lunzen J, Maggiolo F, Phing B, et al. Rapid, robust and sustained antiviral response with once-daily dolutegravir, a next generation integrase inhibitor in combination therapy in antiretroviral-naïve adults: 48 week results from SPRING-1. Presented at: 6th IAS Conference; July 17-20, 2011; Rome, Italy. Abstract TUAB01.
    • (2011) 6th IAS Conference
    • Van Lunzen, J.1    Maggiolo, F.2    Phing, B.3
  • 16
    • 70349296826 scopus 로고    scopus 로고
    • Identification of ongoing human immunodeficiency virus type 1 (HIV-1) replication in residual viremia during recombinant hiv-1 poxvirus immunizations in patients with clinically undetectable viral loads on durable suppressive highly active antiviral therapy
    • Shiu C, Cunningham CK, Greenough T, et al. Identification of ongoing human immunodeficiency virus type 1 (HIV-1) replication in residual viremia during recombinant HIV-1 poxvirus immunizations in patients with clinically undetectable viral loads on durable suppressive highly active antiviral therapy. J Virol. 2009;83:9731-9742.
    • (2009) J Virol , vol.83 , pp. 9731-9742
    • Shiu, C.1    Cunningham, C.K.2    Greenough, T.3
  • 18
    • 0028874048 scopus 로고
    • Rapid turnover of plasma virions and cd4 lymphocytes in hiv-1 infection
    • Ho DD, Neumann AU, Perelson AS, et al. Rapid turnover of plasma virions and CD4 lymphocytes in hIV-1 infection. Nature. 1995;373:123-126.
    • (1995) Nature , vol.373 , pp. 123-126
    • Ho, D.D.1    Neumann, A.U.2    Perelson, A.S.3
  • 19
    • 0028811974 scopus 로고
    • Viral dynamics in human immunodeficiency virus type 1 infection
    • Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 1995;373:117-122.
    • (1995) Nature , vol.373 , pp. 117-122
    • Wei, X.1    Ghosh, S.K.2    Taylor, M.E.3
  • 22
    • 39749112383 scopus 로고    scopus 로고
    • Low-level hiv-1 replication and the dynamics of the resting cd4+ T cell reservoir for hiv-1 in the setting of HAART
    • Sedaghat AR, Siliciano RF, Wilke CO. Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART. BMC Infect Dis. 2008;8:1-14.
    • (2008) BMC Infect Dis , vol.8 , pp. 1-14
    • Sedaghat, A.R.1    Siliciano, R.F.2    Wilke, C.O.3
  • 24
    • 77950537810 scopus 로고    scopus 로고
    • Hiv-1 replication and immune dynamics are affected by raltegravir intensification of haart-suppressed subjects
    • Buzon MJ, Massanella M, Llibre JM, et al. HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects. Nat Med. 2010;16:460-465.
    • (2010) Nat Med , vol.16 , pp. 460-465
    • Buzon, M.J.1    Massanella, M.2    Llibre, J.M.3
  • 25
    • 77949592502 scopus 로고    scopus 로고
    • Antiretroviral intensification and valproic acid lack sustained effect on residual hiv-1 viremia or resting cd4+ cell infection
    • Archin NM, Cheema M, Parker D, et al. Antiretroviral intensification and valproic acid lack sustained effect on residual HIV-1 viremia or resting CD4+ cell infection. PLoS One. 2010;5:1-4.
    • (2010) PLoS One , vol.5 , pp. 1-4
    • Archin, N.M.1    Cheema, M.2    Parker, D.3
  • 26
    • 77749277080 scopus 로고    scopus 로고
    • Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with hiv-1 suppression during receipt of combination antiretroviral therapy
    • McMahon D, Jones J, Wiegand A, et al. Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy. Clin Infect Dis. 2010;50:912-919.
    • (2010) Clin Infect Dis , vol.50 , pp. 912-919
    • McMahon, D.1    Jones, J.2    Wiegand, A.3
  • 27
    • 78751616765 scopus 로고    scopus 로고
    • The significance of very lowlevel viremia detected by sensitive viral load assays in HIV infected patients on HAART
    • Widdrington J, Payne B, Medhi M, et al. The significance of very lowlevel viremia detected by sensitive viral load assays in HIV infected patients on HAART. J Infect. 2011;62:87-92.
    • (2011) J Infect , vol.62 , pp. 87-92
    • Widdrington, J.1    Payne, B.2    Medhi, M.3
  • 28
    • 84863115427 scopus 로고    scopus 로고
    • Plasma hiv-1 RNA detection below 50 copies/ml and risk of virologic rebound in patients receiving highly active antiretroviral therapy
    • Doyle T, Smith C, Vitiello P, et al. Plasma HIV-1 RNA detection below 50 copies/ml and risk of virologic rebound in patients receiving highly active antiretroviral therapy. Clin Infect Dis. 2012;54:729-737.
    • (2012) Clin Infect Dis , vol.54 , pp. 729-737
    • Doyle, T.1    Smith, C.2    Vitiello, P.3
  • 29
    • 84859178656 scopus 로고    scopus 로고
    • Residual viremia does not influence 1 year virological rebound in hiv-infected patients with hiv-rna persistently below 50 copies/ml
    • Gianotti N, Galli L, Racca S, et al. Residual viremia does not influence 1 year virological rebound in HIV-infected patients with HIV-rna persistently below 50 copies/ml. J Antimicrob Chemother. 2012;67:213-217.
    • (2012) J Antimicrob Chemother , vol.67 , pp. 213-217
    • Gianotti, N.1    Galli, L.2    Racca, S.3
  • 30
    • 78650230394 scopus 로고    scopus 로고
    • Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level
    • Lima VD, Bangsberg DR, Harrigan PR, et al. Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level. J Acquir Immune Defic Syndr. 2010;55:460-465.
    • (2010) J Acquir Immune Defic Syndr , vol.55 , pp. 460-465
    • Lima, V.D.1    Bangsberg, D.R.2    Harrigan, P.R.3
  • 31
    • 84856896754 scopus 로고    scopus 로고
    • Plasma hiv-1 RNA levels during antiretroviral therapy: How low is low enough?
    • Gandhi RT, Deeks SG. Plasma HIV-1 RNA levels during antiretroviral therapy: how low is low enough? Clin Infect Dis. 2012;54:1-3.
    • (2012) Clin Infect Dis , vol.54 , pp. 1-3
    • Gandhi, R.T.1    Deeks, S.G.2
  • 32
    • 56749149574 scopus 로고    scopus 로고
    • Determinants of virologic failure after successful viral load suppression in first-line highly active antiretroviral therapy
    • Geretti AM, Smith C, Haberl A, et al. Determinants of virologic failure after successful viral load suppression in first-line highly active antiretroviral therapy. Antivir Ther. 2008;13:927-936.
    • (2008) Antivir Ther , vol.13 , pp. 927-936
    • Geretti, A.M.1    Smith, C.2    Haberl, A.3
  • 35
    • 34047198735 scopus 로고    scopus 로고
    • Pilot study of a novel short-cycle antiretroviral treatment interruption strategy: 48-Week results of the five-days-on, two-days-off (FOTO) study
    • DOI 10.1310/hct0801-19
    • Cohen CJ, Colson AE, Sheble-Hall AG, et al. Pilot study of a novel shortcycle antiretroviral treatment interruption strategy: 48-week results of the five-days-on, two-days-off (FOTO) study. Antivir Ther. 2010;8:19-23. (Pubitemid 46542906)
    • (2007) HIV Clinical Trials , vol.8 , Issue.1 , pp. 19-23
    • Cohen, C.J.1    Colson, A.E.2    Sheble-Hall, A.G.3    McLaughlin, K.A.4    Morse, G.D.5
  • 36
    • 79960443775 scopus 로고    scopus 로고
    • Detection of drug resistance mutations at low plasma hiv-1 RNA load in a european multicenter cohort study
    • Prosperi MCF, Mackie N, Di Giambenedetto S, et al. Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicenter cohort study. J Antimicrob Chemother. 2011;66:1886-1896.
    • (2011) J Antimicrob Chemother , vol.66 , pp. 1886-1896
    • Prosperi, M.C.F.1    MacKie, N.2    Di Giambenedetto, S.3
  • 37
    • 77950923702 scopus 로고    scopus 로고
    • Antiretroviral drug resistance in hiv-1-infected patients with low-level viremia
    • Mackie NE, Phillips AN, Kaye S, et al. Antiretroviral drug resistance in HIV-1-infected patients with low-level viremia. J Infect Dis. 2010;201:1303-1307.
    • (2010) J Infect Dis , vol.201 , pp. 1303-1307
    • Mackie, N.E.1    Phillips, A.N.2    Kaye, S.3
  • 39
    • 12344313124 scopus 로고    scopus 로고
    • Low-level viremia and proviral DNA impede immune reconstitution in HIV-1-infected patients receiving highly active antiretroviral therapy
    • DOI 10.1086/427340
    • Ostrowski SR, Katzenstein TL, Thim PT, et al. Low-level viremia and proviral DNA impede immune reconstruction in HIV-1-infected patients receiving highly active antiretroviral therapy. J Infect Dis. 2005;191: 348-357. (Pubitemid 40139759)
    • (2005) Journal of Infectious Diseases , vol.191 , Issue.3 , pp. 348-357
    • Ostrowski, S.R.1    Katzenstein, T.L.2    Thim, P.T.3    Pedersen, B.K.4    Gerstoft, J.5    Ullum, H.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.